We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$26B
AUM Growth
+$926M
Cap. Flow
-$759M
Cap. Flow %
-2.91%
Top 10 Hldgs %
34.84%
Holding
584
New
79
Increased
150
Reduced
231
Closed
76

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$179M
2
META icon
Meta Platforms (Facebook)
META
+$175M
3
DIS icon
Walt Disney
DIS
+$147M
4
NKE icon
Nike
NKE
+$146M
5
AAPL icon
Apple
AAPL
+$141M

Sector Composition

Rank Sector Weight
1 Technology 29.14%
2 Healthcare 22.1%
3 Consumer Discretionary 13.75%
4 Financials 10.22%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
326
Eaton
ETN
$157B
$1.21M ﹤0.01%
14,501
-358
-2% -$29K
NEO icon
327
NeoGenomics
NEO
$1.81B
$1.21M ﹤0.01%
55,000
+7,000
+15% +$154K
GSK icon
328
GSK
GSK
$103B
$1.19M ﹤0.01%
23,859
-6,393
-21% -$321K
PUMP icon
329
ProPetro Holding
PUMP
$1.45B
$1.19M ﹤0.01%
+57,617
New +$1.22M
AMGN icon
330
Amgen
AMGN
$203B
$1.15M ﹤0.01%
6,263
-288
-4% -$51.6K
MDGL icon
331
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.15M ﹤0.01%
11,000
-7,333
-40% -$785K
CQP icon
332
Cheniere Energy
CQP
$31.8B
$1.14M ﹤0.01%
27,028
+908
+3% +$38.6K
IQV icon
333
IQVIA
IQV
$34.7B
$1.13M ﹤0.01%
7,035
+7,000
+20,000% +$982K
KYNB
334
Kyntra Bio
KYNB
$28.5M
$1.13M ﹤0.01%
1,000
+80
+9% +$87.6K
GOSS icon
335
Gossamer Bio
GOSS
$66.5M
$1.11M ﹤0.01%
50,000
-5,000
-9% -$95.7K
OKE icon
336
Oneok
OKE
$58.7B
$1.09M ﹤0.01%
15,844
-388
-2% -$26.2K
ATNX
337
DELISTED
Athenex, Inc. Common Stock
ATNX
$1.09M ﹤0.01%
+2,750
New +$762K
CONE
338
DELISTED
CyrusOne Inc Common Stock
CONE
$1.08M ﹤0.01%
18,803
-466
-2% -$27.3K
SILK
339
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.04M ﹤0.01%
+21,500
New +$914K
HALO icon
340
Halozyme
HALO
$9.72B
$1.03M ﹤0.01%
60,000
-175,121
-74% -$2.83M
PXD
341
DELISTED
Pioneer Natural Resource Co.
PXD
$1.02M ﹤0.01%
6,618
-318,529
-98% -$48.8M
GILD icon
342
Gilead Sciences
GILD
$161B
$999K ﹤0.01%
14,783
-361
-2% -$23.7K
HRTX icon
343
Heron Therapeutics
HRTX
$86.3M
$961K ﹤0.01%
+51,670
New +$1.03M
ACN icon
344
Accenture
ACN
$89.9B
$958K ﹤0.01%
5,183
+686
+15% +$123K
DRI icon
345
Darden Restaurants
DRI
$22.5B
$954K ﹤0.01%
7,839
-193
-2% -$23K
STAY
346
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$931K ﹤0.01%
55,097
-1,375
-2% -$24.3K
ARQL
347
DELISTED
Arqule Inc
ARQL
$881K ﹤0.01%
+80,000
New +$557K
JCI icon
348
Johnson Controls International
JCI
$87.5B
$878K ﹤0.01%
21,242
-5,904
-22% -$227K
SYK icon
349
Stryker
SYK
$127B
$877K ﹤0.01%
4,265
-8,845
-67% -$1.69M
BHVN
350
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$876K ﹤0.01%
+20,000
New +$1.13M

Similar funds

Fred Alger Management's Q2 2019 Portfolio in Review

As of Q2 2019, Fred Alger Management held 584 positions worth $26B, up 3.7% from $25.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fred Alger Management's Q2 2019 filing shows 79 new, 150 increased, 231 reduced and 76 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 2,145,722 shares worth $65.1M. The largest sale was Alphabet (Google) Class C, an estimated $368M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fred Alger Management's largest Q2 2019 buy was Pluralsight, Inc. Class A Common Stock: 2,145,722 shares worth $65.1M.
  • Fred Alger Management added most to Qualcomm in Q2 2019, an estimated $179M increase.
  • Fred Alger Management's biggest Q2 2019 reduction was Alphabet (Google) Class C, cutting an estimated $368M.
  • Fred Alger Management fully exited Cognizant in Q2 2019, selling an estimated $51M.
  • Fred Alger Management's ten largest holdings make up 35% of its $26B portfolio in Q2 2019.
  • Fred Alger Management opened 79 new positions and closed 76 in Q2 2019.
  • Fred Alger Management's portfolio value rose 3.7% quarter-over-quarter to $26B.

Based on Fred Alger Management's 13F filing for Q2 2019, filed 14 Aug 2019.